Different optimizing strategies based on spot scanning carbon ion therapy for non-small cell lung cancer
Liu Xiaoli, Kambiz Shahnazi, Mao Jingfang, Xu Wenjian
Department of Medical Physics,Shanghai Proton and Heavy Ion Center;Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy,Shanghai 201321,China (Liu XL,Shahnazi K,Xu WJ);
Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy ;
Department of Radiation Oncology,Shanghai Proton and Heavy Ion Center Shanghai 201321,China;
department of Radiation Oncology,FuDan University Shanghai Cancer Center,Shanghai 200032 China(Mao JF)
Objective To evaluate the dose variation of target coverage and organs at risk (OARs) among four planning strategies using spot-scanning carbon-ion radiotherapy for non-small cell lung cancer (NSCLC). Methods Ten NSCLC patients utilizing gating motion control were selected to receive dose calculation over multiple acquired 4DCT images. Four optimizing strategies consisted of intensity-modulated carbon-ion therapy (IMCT-NoAS),IMCT combined with internal gross tumor volume (IGTV) assigned muscle (IMCT-ASM),single beam optimization (SBO)(SBO-NoAS) and SBO combined with IGTV assigned muscle (SBO-ASM).The initial plan was re-calculated after the 4DCT data were reviewed and then compared with the initial plan in the dosimetry. Results For re-calculation plans with two reviewing CTs,all four strategies yielded similar planning target volume (PTV) coverage. Merely IMCT-NoAS strategy presented with relatively significant variations in dose distribution. Dose variation for OARs between initial and re-calculated plans:for all four strategies,V20 of ipsilateral lung was increased by approximately 2.0 Gy (relative biological effective dose,RBE),V30 of heart was increased by approximately 1.0 Gy (RBE) for both IGTV assigned muscle strategies,whereas decreased by approximately 0.2 Gy (RBE) for both IGTV non-assigned muscle strategies. The maximum dose of spinal cord was changed by 2.5 Gy (RBE). Conclusions Carbon-ion radiotherapy is sensitive to the anatomic motion within the tumors along the beam path. When the tumor motion along the head-foot (H-F) direction exceeds 8 mm,SBO-ASM strategy provides better dose coverage of target. Strategies with IGTV assignment may result in dose overshoot to a position deeper than the initial planning dose distribution.
Liu Xiaoli,Kambiz Shahnazi,Mao Jingfang et al. Different optimizing strategies based on spot scanning carbon ion therapy for non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(11): 994-998.
[1] Schardt D,Schulz-Ertner D.Heavy-ion tumor therapy:physical and radiobiological benefits[J].Med Phys,2010,82(1):383-425.DOI:10.1103/remodphys.82.383.
[2] Fujii O,Demizu Y,Hashimoto N,et al. A retrospective comparison of proton therapy and carbon ion therapy for stage Ⅰ non-small cell lung cancer[J].Radiother Oncol,2013,109(1):32-37.DOI:10.1016/j.radonc.2013.08.038.
[3] Suit H,DeLaney T,Goldberg S,et al. Proton vs. carbon ion beams in the definitive radiation treatment of cancer patients[J].Radiother Oncol,2010,95(1):3-22.DOI:10.1016/j.radonc.2010.01.015.
[4] Zhou GH,Zhang XD,Starkschal G,et al. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer[J].Int J Radiat Oncol Biol Phys,2008,72(5):1385-1395.DOI:10.1016/j.ijrobp.2008.03.007.
[5] Chang JY,Liu HH,Komaki R,et al. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer[J].Curr Oncol Rep,2005,7(4):255-259.DOI:10.1007/s11912-005-0047-4.pdf.
[6] Shinichiro M,Lu M,Wolfgang JA,et al. Effects of interfractional anatomical changes on water-equivalent pathlength in charged-particle radiotherapy of lung cancer[J].J Radiat Res,2009,50(6):513-519.DOI:10.1269/jrr.09032.
[7] Park PC,Zhu XR,Lee A,et al. A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties[J].Int J Radiat Oncol Biol Phys,2012,82(2):329-336.DOI:10.1016/j.ijrobp.2011.05.011.
[8] Kang Y,Zhang XD,Chang JY,et al.4D CT proton treatment planning strategy for mobile lung tumors[J].Int J Radiat Oncol Biol Phys,2007,67(3):906-914.DOI:10.1016/j.ijrobp.2006.10.045.
[9] Bert C,Durante M.Motion in radiotherapy:particle therapy[J].Phys Med Biol,2011,56(16):113-144.DOI:10.1088/0031-9155/56/16/R01.
[10] Minohara S,Kanai T,Endo M,et al. Respiratorytory gating irridiation system for heavy heavy ion therapy[J].Int J Radiat Oncol Biol Phys,2000,47(4):1097-1103.DOI:10.1016/S0360-3016(00)00524-1.
[11] Zhang Y,Yang J.Zhang LF,et al. Modeling respiratory motion for reducing motion artifacts in 4DCT images[J].Med Phys,2013,40:041716.DOI:10.1118/1.4795133.
[12] Dobashi S,Sugane T,Mori S,et al. Intrafractional respiratory motion for charged particle lung therapy with immobilization assessed by four-dimensional computed tomography[J].J Radiat Res,2011,52(1),96-102.DOI:10.1269/jrr.10019.
[13] Eley J,Newhauser W,Richter D,et al. Robustness of target dose coverage to motion uncertainties for scanned carbon ion beam tracking therapy of moving tumors[J].Phys Med Biol,2015,60(4):1717-1740.DOI:10.1088/0031-9155/60/4/1717
[14] Van de Water S,Kreuger R,Zenklusen S,et al. Tumour tracking with scanned proton beams:assessing the accuracy and practicalities[J].Phys Med Biol,2009,54(21):6549-6563.DOI:10.1088/0031-9155/54/21/007.
[15] Furukawa T,Inaniwa T,Sato S,et al. Moving target irradiation with fast rescanning and gating in particle therapy[J].Med Phys,2010,37(9):4874-4879.DOI:10.1118/1.3481512.
[16] Parodi K,Paganetti H,Shih H,et al. Patient study of in vivo verification of beam delivery and range,using positron emission tomography and computed tomography imaging after proton therapy[J].Int J Radiat Oncol Biol Phys,2007,68(3):920-934.DOI:10.1016/j.ijrobp.2007.01.063.
2018, Vol. 27 
